| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 05/03/2000 | EP0514481B1 Merosin, nucleic acids encoding, fragments and uses thereof |
| 05/03/2000 | EP0383803B1 Oligonucleotide-polyamide conjugates |
| 05/03/2000 | CN1252128A Measurement of stress levels in polymeric compositions |
| 05/03/2000 | CN1251901A Reagent kit for early detection and evaluation of tumor and its preparing process |
| 05/03/2000 | CA2252727A1 Polyglutamine containing proteins and use thereof for diagnosis and treatment of cag repeat-linked neuropsychiatric disorders |
| 05/02/2000 | US6057773 Unanchored sensor for fluid characteristics |
| 05/02/2000 | US6057755 Automotive carbon monoxide detection system |
| 05/02/2000 | US6057693 Dielectric mixture composition sensor with compensation for mixture electrical conductivity |
| 05/02/2000 | US6057435 Nucleic acid coding for polypeptide which binds to receptor tyrosine kinase containing immunoglobulin-like and epidermal growth factor homology domains expressed in vascular endothelial cells; diagnosis/imaging; angiogenesis inhibition |
| 05/02/2000 | US6057433 Nucleotide sequences; used for screening compounds which bind to the receptor or which suppress ligand binding to the receptor |
| 05/02/2000 | US6057432 CysS |
| 05/02/2000 | US6057429 Phosphatase activated crosslinking, conjugating and reducing agents; methods of using such agents; and reagents comprising phosphatase activated crosslinking and conjugating agents |
| 05/02/2000 | US6057428 Variants of vascular endothelial cell growth factor |
| 05/02/2000 | US6057426 Nucleotide and amino acid sequences of polypeptide capable of inducing leukocyte migration and/or activating leukocytes in a dose-dependent manner; diagnosis/screening/therapy; for increasing cell layer permeability for drug circulation |
| 05/02/2000 | US6057425 Solid phase synthesis of peptides where prior to cleavage and deprotection, the protected resin peptide is reswelled with dichloromethane |
| 05/02/2000 | US6057423 Screening a recombinantly-produced or chemically-synthesized molecular library to identify compounds which suppress binding between human mucosal lymphocyte-1 antigen comprising an integrin alpha e chain and an epithelial cell in vitro |
| 05/02/2000 | US6057362 Protease inhibitors |
| 05/02/2000 | US6057167 For hybridization detection chips; magnetic field associated with molecule modifies an electrical characteristic of the magnetoresistive member when the molecule binds with a molecular receptor |
| 05/02/2000 | US6057166 Fecal test method |
| 05/02/2000 | US6057165 Quality control procedure for membrane flow-through diagnostic assay devices |
| 05/02/2000 | US6057164 Screening of protein fractions for fragments within a range 20 to 50 kilodaltons; if fragments are present, then additional steps are necessary for processing into preparations free of side effects |
| 05/02/2000 | US6057162 Disease diagnosis by vapor sample analysis |
| 05/02/2000 | US6057161 Method for determination of drugs of abuse in biological samples |
| 05/02/2000 | US6057160 Methods for preparation and use of a coomassie brilliant blue/protein complex |
| 05/02/2000 | US6057159 Processes for identifying a solvent condition suitable for determining a biophysical property of a protein |
| 05/02/2000 | US6057142 Human chitinase, its recombinant production, its use for decomposing chitin, its use in therapy or prophylaxis against infection diseases |
| 05/02/2000 | US6057126 Polynucleotide sequence coding human binding polypeptide associated with signal transduction; for treatment and prevention of cancer, inflammation, psoriasis and arthritis; wound healing agents; antiproliferative agents |
| 05/02/2000 | US6057124 Nucleic acids encoding ligands for HEK4 receptors |
| 05/02/2000 | US6057120 Quantitative or qualitative detection of analyte by contacting sample with indicator and detecting change in property of reagent; reagent is stable in reduced and oxidized forms |
| 05/02/2000 | US6057119 Detecting modulators of a mutant interleukin enzyme; using a three dimensional structure of interleukin enzyme, adjusting amino acid sequence, choosing and synthesizing modulator, incubating with mutant to test efficiency of enzyme inhibitor |
| 05/02/2000 | US6057117 Identification and use of selective inhibitors of glycogen synthase kinase 3 |
| 05/02/2000 | US6057116 Melanoma and prostate cancer specific antibodies for immunodetection and immunotherapy |
| 05/02/2000 | US6057115 Process for producing GM2 specific antibodies |
| 05/02/2000 | US6057114 Automated assays and methods for detecting and modulating cell surface protein function |
| 05/02/2000 | US6057107 Methods and compositions for flow cytometric determination of DNA sequences |
| 05/02/2000 | US6057104 Disruption of the mammalian Rad51 protein and disruption of proteins that associate with mammalian Rad51 for hindering cell proliferation |
| 05/02/2000 | US6057103 Detecting proteins coded in genomic nucleotide sequences; obtaining single stranded nucleotide sequences, incubating with probe, isolating bound nucleotide sequences, transforming cells, recovering desired proteins |
| 05/02/2000 | US6057101 Identification and comparison of protein-protein interactions that occur in populations and identification of inhibitors of these interactors |
| 05/02/2000 | US6057097 Marker for pathologies comprising an auto-immune reaction and/or for inflammatory diseases |
| 05/02/2000 | US6057096 Photocleavable agents and conjugates for the detection and isolation of biomolecules |
| 05/02/2000 | US6057092 Screening for the position of labeled compound in multicompartment cell; contacting tissue, cell or organelle with labeled compound, visibly observe the appearance of labeled compound in unlabeled compartment over time |
| 05/02/2000 | US6057091 Detection of modulators of a cholesterol transport protein; incubate transpot protein and modulator and compare cholestrol transport in it presence and absence |
| 05/02/2000 | US6056959 CD40 antigen antibody complex |
| 05/02/2000 | US6056922 Bilayer membrane device |
| 05/02/2000 | US6056920 Process for identifying a solvent condition suitable for determining a biophysical property of a protein |
| 05/02/2000 | US6056861 Process and device for generating resonance phenomena in particle suspensions |
| 05/02/2000 | US6055867 Panel testing apparatus and method |
| 05/02/2000 | US6055860 Method for measuring vehicle damage |
| 05/02/2000 | US6055850 Multi-directional permeameter |
| 05/02/2000 | US6055849 Gas detector and its adjusting method |
| 05/02/2000 | US6055847 Measuring sensor having metal jacket lead and externally mounted threaded connector |
| 05/02/2000 | US6055840 Method and apparatus for determining concentration of a gas |
| 05/02/2000 | CA2287709A1 Capillary electrophoretic apparatus, sample plate and sample injection method |
| 05/02/2000 | CA2287687A1 Method and device for the generation of data for the diagnosis of the degree of injury to a patient's skin tissue |
| 05/02/2000 | CA2189858C Method and means of quantifying performance chemicals in pulp and paper |
| 05/02/2000 | CA2105057C Dna sequences which code for virulence characteristics of streptococcus suis and part thereof polypeptides and antibodies derived therefrom and the use thereof for the diagnosis of and protection against infection by s. suis in mammals, including man |
| 05/02/2000 | CA2104014C Structural gene of pneumococcal protein |
| 05/02/2000 | CA2023968C Living tissue equivalents |
| 05/02/2000 | CA2011878C Immunogenic regions on the e7 protein of human papillomavirus type 16 |
| 05/02/2000 | CA1340982C Protamine-reactive igm antibodies |
| 04/30/2000 | CA2281168A1 Spectrophotometric apparatus for reducing fluid carryover |
| 04/30/2000 | CA2269199A1 Mutations of the 5' region of the human 5-ht1a gene, associated proteins of the 5' region and a diagnostic test for major depression and related mental illnesses |
| 04/27/2000 | WO2000023955A1 Virus-like particles for the induction of autoantibodies |
| 04/27/2000 | WO2000023933A1 Systems and methods for analysis of genetic networks |
| 04/27/2000 | WO2000023807A1 Method and apparatus for wash, resuspension, recollection and localization of magnetizable particles in assays using magnetic separation technology |
| 04/27/2000 | WO2000023806A1 Detection and quantification of vancomycin in biological fluids |
| 04/27/2000 | WO2000023805A1 Method for detecting an analyte and kit |
| 04/27/2000 | WO2000023804A1 Method for detecting the enzymatic activity of the poly(adp-ribose polymerase) enzyme |
| 04/27/2000 | WO2000023802A1 Method for measuring cellular adhesion |
| 04/27/2000 | WO2000023801A1 System for applying controlled pressure profiles to biological samples and methods relating thereto |
| 04/27/2000 | WO2000023800A1 Reagent composition and method for identification of reticulated cells |
| 04/27/2000 | WO2000023799A1 Protein quantitation with cell imaging densitometry |
| 04/27/2000 | WO2000023793A1 Optical sensor having dielectric film stack |
| 04/27/2000 | WO2000023792A1 Methods of concentrating microorganisms using affinity separation |
| 04/27/2000 | WO2000023785A2 Improvements in luminescence assays |
| 04/27/2000 | WO2000023784A2 Method of detecting risk of type ii diabetes based on mutations found in carboxypeptidase e |
| 04/27/2000 | WO2000023625A2 Isolated nucleic acid molecules which encode scp proteins, and uses thereof |
| 04/27/2000 | WO2000023624A1 Methods of screening for risk of proliferative disease and methods for the treatment of proliferative disease |
| 04/27/2000 | WO2000023622A1 Methods for manipulating complex nucleic acid populations using peptide-labeled oligonucleotides |
| 04/27/2000 | WO2000023621A2 Visualization of rna in living cells |
| 04/27/2000 | WO2000023618A1 Polymorphism in a tgf-beta gene correlated to osteoporosis |
| 04/27/2000 | WO2000023617A2 Housing box for electronic chip with biological probes |
| 04/27/2000 | WO2000023615A2 Method for extracting quantitative information relating to an influence on a cellular response |
| 04/27/2000 | WO2000023613A1 A method of assessing a matter associated with parturition in a pregnant individual |
| 04/27/2000 | WO2000023612A1 Enzymatic methods for measuring lysophospholipids and phospholipids and correlation with diseases |
| 04/27/2000 | WO2000023610A1 Method for screening compound inhibiting signal transduction of inflammatory cytokine |
| 04/27/2000 | WO2000023602A2 Regulated expression using conditional er retention domains |
| 04/27/2000 | WO2000023590A2 INHIBITION OF CD40-MEDIATED NFλB ACTIVATION |
| 04/27/2000 | WO2000023588A2 G-protein coupled receptors |
| 04/27/2000 | WO2000023583A2 p53 BINDING AREAS |
| 04/27/2000 | WO2000023581A1 Dual reporter system and methods of use therefor |
| 04/27/2000 | WO2000023576A2 Secretases related to alzheimer's dementia |
| 04/27/2000 | WO2000023575A1 Ups (ugc) |
| 04/27/2000 | WO2000023572A1 Tnfr related gene 12 |
| 04/27/2000 | WO2000023570A1 Altering the properties of cells or of particles with membranes derived from cells by means of lipid-modified proteinaceous molecules |
| 04/27/2000 | WO2000023569A1 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema |
| 04/27/2000 | WO2000023568A2 Methods and compositions for decreasing mitochondrial overproduction of reactive oxygen species in cells |
| 04/27/2000 | WO2000023478A1 Squaric acid activated carrier usable for immobilisation of compounds containing amine groups |
| 04/27/2000 | WO2000023474A1 Protein engineering |
| 04/27/2000 | WO2000023470A1 Isolated proteins and nucleic acid molecules having homology to the nip2 protein and uses thereof |